1) portal vein chemotherapy
门静脉化疗
1.
Influence of hepatectomy combined with hepaticer artery ligation and portal vein chemotherapy for hepatocellular carcinoma on the expression of MDR-1 and MRP and significance;
肝癌切除术并肝动脉结扎和门静脉化疗对复发肝癌表达MDR1和MRP的影响及意义
2.
Portal vein chemotherapy in early stage in preventing postoperative cancer of the large intestine from transfering cancer of the liver;
手术后早期门静脉化疗预防大肠癌肝转移
3.
Clinical study of treatment of primary hepatic carcinoma by hepatectomy combined with portal vein chemotherapy;
门静脉化疗配合肝切除治疗原发性肝癌临床研究
3) port vein infussion
门静脉辅助化疗
4) Percutaneous portal vein chemoembolization
门静脉栓塞化疗
5) Portal/ther
门静脉/治疗
6) SPVC
选择性门静脉化疗
1.
objective: To evaluate the clinical significance of selective portal vein chemotherapy (SPVC) and percutaneous ethanol injection therapy (PEIT) guided by color Doppler ultrasonography (CDU) after transhepatic arterial chemo-embolization (TACE).
目的 :探讨彩超引导下经皮经肝选择性门静脉化疗 ( SPVC)结合瘤内无水酒精注射疗法 ( PEIT)联合肝动脉栓塞化疗 ( TACE)治疗中晚期肝癌的临床应用价值。
补充资料：门静脉插管化疗栓塞术
门静脉插管化疗栓塞术
the chemo?embolization of portal vein
由门静脉属支插管至或近门静脉的肿瘤分支，经该导管进行化学栓塞治疗的方法。门静脉参与肝癌血供及门静脉癌栓是肝癌肝内转移、复发及影响其预后的重要因素。故通过脐静脉、胃网膜静脉、回结肠静脉或经皮肝门静脉穿刺插管等方式，将导管送至或近其肿瘤分支处，如用带球囊导管则先膨胀球囊以防止栓塞剂反流，经导管注入抗癌药及栓塞剂；常用抗癌药有阿霉素、丝裂霉素、氟尿嘧啶、顺铂等；栓塞剂如碘油、明胶海绵粒、自凝血块、纤维蛋白等。该法常与肝动脉栓塞术合并使用，疗效较单一栓塞术好。肿瘤及门静脉癌栓的坏死率更高，但相应的肝组织损伤较大，须掌握好其适应证。
说明：补充资料仅用于学习参考，请勿用于其它任何用途。
参考词条